[go: up one dir, main page]

FR2960781B1 - Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue - Google Patents

Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue

Info

Publication number
FR2960781B1
FR2960781B1 FR1054443A FR1054443A FR2960781B1 FR 2960781 B1 FR2960781 B1 FR 2960781B1 FR 1054443 A FR1054443 A FR 1054443A FR 1054443 A FR1054443 A FR 1054443A FR 2960781 B1 FR2960781 B1 FR 2960781B1
Authority
FR
France
Prior art keywords
preparation
oral vaccine
live virus
attenuated live
dry oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1054443A
Other languages
English (en)
Other versions
FR2960781A1 (fr
Inventor
Pierre Chouvenc
Alain Francon
Catherine Noel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Inc
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Priority to FR1054443A priority Critical patent/FR2960781B1/fr
Priority to PCT/EP2011/002760 priority patent/WO2011154119A1/fr
Publication of FR2960781A1 publication Critical patent/FR2960781A1/fr
Application granted granted Critical
Publication of FR2960781B1 publication Critical patent/FR2960781B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR1054443A 2010-06-07 2010-06-07 Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue Expired - Fee Related FR2960781B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1054443A FR2960781B1 (fr) 2010-06-07 2010-06-07 Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue
PCT/EP2011/002760 WO2011154119A1 (fr) 2010-06-07 2011-06-06 Fabrication d'un vaccin sec stabilisé à administration par voie orage à partir d'un virus vivant atténué

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1054443A FR2960781B1 (fr) 2010-06-07 2010-06-07 Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue

Publications (2)

Publication Number Publication Date
FR2960781A1 FR2960781A1 (fr) 2011-12-09
FR2960781B1 true FR2960781B1 (fr) 2013-11-22

Family

ID=44312310

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1054443A Expired - Fee Related FR2960781B1 (fr) 2010-06-07 2010-06-07 Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue

Country Status (2)

Country Link
FR (1) FR2960781B1 (fr)
WO (1) WO2011154119A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3581202A1 (fr) * 2018-06-14 2019-12-18 University College Cork-National University of Ireland, Cork Composition et procédé de stabilisation de vaccins dans un format de dosage solide
CN110585439B (zh) * 2019-09-30 2023-06-09 长春生物制品研究所有限责任公司 一种改良型的冻干甲型肝炎减毒活疫苗稳定剂、疫苗半成品、疫苗成品及其制备方法
CN116874555B (zh) * 2023-09-08 2023-11-28 成都华任康生物科技有限公司 一种置换液及其试剂盒和相关应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8801338D0 (en) 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
DD299213A7 (de) 1988-05-04 1992-04-09 Saechsische Landesgewerbefoerderungsgesellschaft M.B.H.,De Verfahren zur stabilisierung eines lebendvirusimpfstoffes gegen temperatureinwirkung
FR2702660B1 (fr) 1993-03-17 1995-05-24 Karl Simpson Compositions thérapeutiques stabilisées et leur procédé de préparation.
FR2742756B1 (fr) * 1995-12-22 1998-04-03 Pasteur Merieux Serums Vacc Stabilisants pour vaccins vivants, vaccins les contenant et procedes pour leur preparation
DE69940354D1 (de) * 1998-11-16 2009-03-12 Introgen Therapeutics Inc Adenovirus-formulierungen zur gentherapie
PL205550B1 (pl) * 1999-08-17 2010-04-30 Smithkline Beecham Biolog Populacja rotawirusa, jego wariant, reasortant i zastosowanie, sposób wytwarzania populacji rotawirusa, kompozycja szczepionki i sposób jej wytwarzania oraz preparat szczepionki
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
KR101130948B1 (ko) 2002-11-01 2012-03-30 글락소스미스클라인 바이오로지칼즈 에스.에이. 건조 공정
BRPI0618850A2 (pt) * 2005-11-21 2011-09-13 Sanofi Pasteur Ltd formulações de estabilização para vìrus recombinantes
EP2143440A1 (fr) 2008-07-09 2010-01-13 Sanofi Pasteur Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
US8557253B2 (en) * 2009-10-07 2013-10-15 Sanofi Pasteur Sa Stabilizing excipient for inactivated whole virus vaccine

Also Published As

Publication number Publication date
WO2011154119A1 (fr) 2011-12-15
FR2960781A1 (fr) 2011-12-09

Similar Documents

Publication Publication Date Title
EP3928800A3 (fr) Composition de poudre sèche comprenant de l'arn à longue chaîne
CY1117861T1 (el) Συνθεση και σκευασμα που περιλαμβανουν ανασυνδυασμενh ανθρωπινη ιδουρονικh 2-σουλφαταση και μεθοδος παρασκευης αυτων
FI3258919T4 (fi) Nasaalinen jauheformulaatio hypoglykemian hoitoon
EA200970844A1 (ru) Способы изготовления восстановленных табачных листов
RU2014142551A (ru) Бездымная табачная композиция, содержащая нетабачные волокна, и способ ее приготовления
BR112015021814A2 (pt) aglomerados respiráveis de partículas carreadoras porosas e fármaco micronizado
MX2015017771A (es) Polipeptidos f de prefusion del virus sincicial respiratorio (rsv) solubles y estabilizados.
RU2014122945A (ru) Композиции для лечения сухости глаза
EA201390409A1 (ru) Составы с низкой дозой панкрелипазы и кишечно-растворимым покрытием
EA201201321A1 (ru) Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
WO2010146598A3 (fr) Vaccin de rotavirus sec et stable, compositions et procédé de préparation de ce dernier
EA033370B1 (ru) Составы рифаксимина и их применение
CO2017012766A2 (es) Unidad de dosificación orodispersable que contiene un componente estetrol
EA201291306A1 (ru) Состав сухого порошка, содержащий антимускариновое средство
JP2013524782A5 (fr)
EA202092926A2 (ru) Лиофилизированные составы, содержащие фактор ix
EA201390810A1 (ru) Жидкие вирусные составы
EA201490395A1 (ru) Способ получения фармацевтических композиций, содержащих финголимод
CY1120396T1 (el) Μεθοδοι για την προετοιμασια και την παραδοση συνθεσεων καυσιμων
MY149924A (en) Lyophilized preparation comprising influenza vaccine, and method for preparation thereof
UA101407C2 (ru) Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат
FR2960781B1 (fr) Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue
EA201490363A1 (ru) Новые составы на основе (триметоксифениламино)пиримидинилов
MX387019B (es) Formulacion farmaceutica parenteral que contiene acido carglumico.
EA201291354A1 (ru) Новое применение диатомитовой земли в фармацевтической промышленности

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20200205